Interest of Procore Needle® for Diagnosis of Lung Cancer

Status

Completed

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT02931461

Enrollment

Registered

2016-10-13

Start date

2016-10-27

Completion date

2018-07-16

Last updated

2020-06-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Endobronchial Transbronchial Needle Aspiration Lung Cancer Procore

Keywords

endobronchial transbronchial needle aspiration lung cancer procore

Brief summary

The ProCore ultrasound biopsy needle, used primarily to obtain intra-abdominal tissue core biopsies, has not been widely used for endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA). In this study the investigators are going to evaluate the utility of the ProCore needle for sampling mediastinal or hilar lymph nodes during EBUS-TBNA versus standard 22 gauge needle for diagnosis of lung cancer.

Interventions

PROCEDUREEndobronchial Ultrasound-Guided Transbronchial Needle Aspiration

Study design

Intervention model

PARALLEL

Primary purpose

OTHER

Masking

NONE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* mediastinal lymphadenopathy \>10 millimeters * lung cancer suspected

Exclusion criteria

* coagulopathy contraindication for midazolam contraindication for bronchoscopy

Design outcomes

Primary

Measure	Time frame
Proportion of histological diagnoses for each needle	6 months

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026